Spyros Papapetropoulos

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
6 years
Director since
2023

6 years of board service in total across 2 boards, counting each seat separately. Longest: Lipocine Inc., 3 years.

Lipocine Inc. Director
3 years · Since 2023
Neuphoria Therapeutics Inc. Director · President and CEO
2 years · Since 2024

Chief executive roles

Neuphoria Therapeutics Inc. · Chief Executive Officer
Since July 2024

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.